Clinical trial
ProspeCtive, nOn-randoMized, MulticENter Clinical Evaluation of Edwards Pericardial Aortic and Mitral Bioprostheses (Models 11000A and 11000M) With a New Tissue Treatment Platform (COMMENCE)
NCT01757665 is registered in ClinicalTrials.gov with Edwards Lifesciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- ProspeCtive, nOn-randoMized, MulticENter Clinical Evaluation of Edwards Pericardial Aortic and Mitral Bioprostheses (Models 11000A and 11000M) With a New Tissue Treatment Platform (COMMENCE)
- Lead sponsor
- Edwards Lifesciences
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- December 11, 2012
- Completion date
- March 23, 2026
- Enrollment
- 777 (actual)
- Sites
- 32
Conditions
As the registry lists them; a condition with its own page is linked.
aortic stenosis, aortic valve insufficiency, heart failure, mitral stenosis, mitral valve insufficiency